Emergent BioSolutions Reports FDA Advisory Committees'
If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use ...
Source: globenewswire.com
Page 7 - Nyse Ebs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse Ebs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Ebs Today - Breaking & Trending Today
Emergent BioSolutions Awarded $379.6 Million Procurement
GAITHERSBURG, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an indefinite-delivery,...
Source: globenewswire.com
Emergent BioSolutions Initiates Phase 1 Study Evaluating
GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in...
Source: globenewswire.com
Emergent BioSolutions to Participate in Investor
GAITHERSBURG, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive...
Source: globenewswire.com
Emergent BioSolutions to Participate in Investor
GAITHERSBURG, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive...
Source: globenewswire.com